Literature DB >> 17426366

Molecular mimicry and auto-immunity.

Miri Blank1, Ori Barzilai, Yehuda Shoenfeld.   

Abstract

The term "molecular mimicry" was coined by R. Damian in 1964, who was first to suggest that antigenic determinants of micro-organisms may resemble antigenic determinants of their host. Damian suggested that this similarity served as a defense mechanism of a microorganism from the host's immune system and prevented the development of immune response to the micro-organism, thereby protecting it from host defense. Years later, the term "molecular mimicry" was attributed a different meaning-namely, antigenic determinants of microorganisms might elicit an auto-immune response that harms the host. The concept of molecular mimicry is based on a structural similarity between a pathogen or metabolite and self-structures. The similarity could be expressed as shared amino acid sequences (linear or mimotope) or similar conformational structure between a pathogen and self-antigen. "Molecular mimicry" has become a very popular explanation for the frequent association of infection with auto-immune disease.

Entities:  

Mesh:

Year:  2007        PMID: 17426366     DOI: 10.1007/BF02686087

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   10.817


  32 in total

1.  Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides.

Authors:  M Blank; Y Shoenfeld; S Cabilly; Y Heldman; M Fridkin; E Katchalski-Katzir
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 2.  Ganglioside mimicry as a cause of Guillain-Barré syndrome.

Authors:  Nobuhiro Yuki; Masaaki Odaka
Journal:  Curr Opin Neurol       Date:  2005-10       Impact factor: 5.710

Review 3.  Infectious origin of the antiphospholipid syndrome.

Authors:  Y Shoenfeld; M Blank; R Cervera; J Font; E Raschi; P-L Meroni
Journal:  Ann Rheum Dis       Date:  2006-01       Impact factor: 19.103

Review 4.  Trypanosoma cruzi-induced molecular mimicry and Chagas' disease.

Authors:  N Gironès; H Cuervo; M Fresno
Journal:  Curr Top Microbiol Immunol       Date:  2005       Impact factor: 4.291

5.  Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo.

Authors:  Azzudin E Gharavi; Silvia S Pierangeli; Ricardo G Espinola; Xiaowei Liu; Margaret Colden-Stanfield; E Nigel Harris
Journal:  Arthritis Rheum       Date:  2002-02

Review 6.  Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.

Authors:  Michael P Pender
Journal:  Trends Immunol       Date:  2003-11       Impact factor: 16.687

7.  Molecular mimicry of an HLA-B27-derived ligand of arthritis-linked subtypes with chlamydial proteins.

Authors:  Manuel Ramos; Iñaki Alvarez; Laura Sesma; Antoine Logean; Didier Rognan; José A López de Castro
Journal:  J Biol Chem       Date:  2002-07-16       Impact factor: 5.157

Review 8.  The Guillain-Barré syndrome: a true case of molecular mimicry.

Authors:  C Wim Ang; Bart C Jacobs; Jon D Laman
Journal:  Trends Immunol       Date:  2004-02       Impact factor: 16.687

Review 9.  Molecular mimicry in halothane hepatitis: biochemical and structural characterization of lipoylated autoantigens.

Authors:  J Gut; U Christen; N Frey; V Koch; D Stoffler
Journal:  Toxicology       Date:  1995-03-31       Impact factor: 4.221

Review 10.  Molecular mimicry: a mechanism for autoimmune injury.

Authors:  L A Barnett; R S Fujinami
Journal:  FASEB J       Date:  1992-02-01       Impact factor: 5.191

View more
  44 in total

Review 1.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  Vasculitis: current status and future directions.

Authors:  Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

3.  Cutting edge issues in autoimmunity.

Authors:  Yaniv Sherer; Torsten Matthias; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

Review 4.  Mycobacterium tuberculosis, autoimmunity, and vitamin D.

Authors:  Yinon Shapira; Nancy Agmon-Levin; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

5.  Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults.

Authors:  Yinon Shapira; Bat-Sheva Poratkatz; Boris Gilburd; Ori Barzilai; Maya Ram; Miri Blank; Staffan Lindeberg; Johan Frostegård; Juan-Manuel Anaya; Nicola Bizzaro; Luis J Jara; Jan Damoiseaux; Yehuda Shoenfeld; Nancy Agmon Levin
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 6.  Molecular mechanisms in autoimmune type 1 diabetes: a critical review.

Authors:  Zhiguo Xie; Christopher Chang; Zhiguang Zhou
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

7.  Response to the comment by Park et al. entitled "is there is a link between Escherichia coli septicaemia and the onset of systemic lupus erythematosus?".

Authors:  Anna Bazsó; Emese Kiss
Journal:  Rheumatol Int       Date:  2013-04-09       Impact factor: 2.631

8.  Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8(+) T Lymphocytes.

Authors:  Wong Yu; Ning Jiang; Peter J R Ebert; Brian A Kidd; Sabina Müller; Peder J Lund; Jeremy Juang; Keishi Adachi; Tiffany Tse; Michael E Birnbaum; Evan W Newell; Darrell M Wilson; Gijsbert M Grotenbreg; Salvatore Valitutti; Stephen R Quake; Mark M Davis
Journal:  Immunity       Date:  2015-05-19       Impact factor: 31.745

9.  Rheumatic diseases and the microbiome.

Authors:  Robert Hal Scofield
Journal:  Int J Rheum Dis       Date:  2014-06       Impact factor: 2.454

10.  Critical role of glycosylation in determining the length and structure of T cell epitopes.

Authors:  Tamás G Szabó; Robin Palotai; Péter Antal; Itay Tokatly; László Tóthfalusi; Ole Lund; György Nagy; András Falus; Edit I Buzás
Journal:  Immunome Res       Date:  2009-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.